ICD-10-CM Code Z16.35

Resistance to multiple antimicrobial drugs

Version 2020 Billable Code Unacceptable Principal Diagnosis

Valid for Submission

Z16.35 is a billable code used to specify a medical diagnosis of resistance to multiple antimicrobial drugs. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code Z16.35 might also be used to specify conditions or terms like infection caused by multi drug resistant bacteria or infection caused by multi drug resistant bacteria or infection due to multidrug resistant acinetobacter or infection due to multidrug resistant acinetobacter baumannii.

The code Z16.35 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

ICD-10:Z16.35
Short Description:Resistance to multiple antimicrobial drugs
Long Description:Resistance to multiple antimicrobial drugs

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code Z16.35:

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • Resistance to multiple antibiotics only Z16.24

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code Z16.35 are found in the index:


Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual’s health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Infection caused by multi drug resistant bacteria
  • Infection caused by multi drug resistant bacteria
  • Infection due to multidrug resistant Acinetobacter
  • Infection due to multidrug resistant Acinetobacter baumannii

Diagnostic Related Groups

The ICD-10 code Z16.35 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 867 - OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC
  • 868 - OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC
  • 869 - OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC

Convert Z16.35 to ICD-9

  • V09.81 - Inf mcrg rstn oth drg ml (Approximate Flag)

Code Classification

  • Factors influencing health status and contact with health services (Z00–Z99)
    • Resistance to antimicrobial drugs (Z16)
      • Resistance to antimicrobial drugs (Z16)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020